Form 4 for IMNM Immunome Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001209191-23-052053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $5.91 | +169.2K | 319.6K | +112% | +$1000.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | P | A | 169,204 | $5.91 | 319,636 | D | — | — |